vs

Side-by-side financial comparison of MicroAlgo Inc. (MLGO) and MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI). Click either name above to swap in a different company.

MARAVAI LIFESCIENCES HOLDINGS, INC. is the larger business by last-quarter revenue ($49.9M vs $26.3M, roughly 1.9× MicroAlgo Inc.). On growth, MARAVAI LIFESCIENCES HOLDINGS, INC. posted the faster year-over-year revenue change (-11.8% vs -35.5%).

MicroAlgo Inc. is a technology enterprise specializing in custom algorithm optimization solutions. It mainly serves clients across smart city management, industrial internet, and e-commerce sectors, helping enterprises improve operational efficiency, reduce operating costs, and optimize data processing performance for real business scenarios.

Maravai LifeSciences Holdings is a global life sciences firm developing critical reagents, diagnostic products, and tech solutions to support biopharma research, drug development, clinical diagnostics, and cell/gene therapy manufacturing. It serves biotech, pharma, research bodies and labs worldwide across three core segments.

MLGO vs MRVI — Head-to-Head

Bigger by revenue
MRVI
MRVI
1.9× larger
MRVI
$49.9M
$26.3M
MLGO
Growing faster (revenue YoY)
MRVI
MRVI
+23.7% gap
MRVI
-11.8%
-35.5%
MLGO

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
MLGO
MLGO
MRVI
MRVI
Revenue
$26.3M
$49.9M
Net Profit
$-35.7M
Gross Margin
25.8%
Operating Margin
-117.9%
Net Margin
-71.6%
Revenue YoY
-35.5%
-11.8%
Net Profit YoY
-37.7%
EPS (diluted)
$-0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MLGO
MLGO
MRVI
MRVI
Q4 25
$49.9M
Q3 25
$41.6M
Q2 25
$26.3M
$47.4M
Q1 25
$46.9M
Q4 24
$34.6M
$56.6M
Q3 24
$69.0M
Q2 24
$40.8M
$69.4M
Q1 24
$64.2M
Net Profit
MLGO
MLGO
MRVI
MRVI
Q4 25
$-35.7M
Q3 25
$-25.6M
Q2 25
$-39.6M
Q1 25
$-29.9M
Q4 24
$4.2M
$-25.9M
Q3 24
$-97.1M
Q2 24
$-9.8M
Q1 24
$-12.1M
Gross Margin
MLGO
MLGO
MRVI
MRVI
Q4 25
25.8%
Q3 25
13.6%
Q2 25
16.4%
Q1 25
16.5%
Q4 24
26.4%
34.3%
Q3 24
46.7%
Q2 24
44.4%
Q1 24
40.3%
Operating Margin
MLGO
MLGO
MRVI
MRVI
Q4 25
-117.9%
Q3 25
-98.6%
Q2 25
-139.8%
Q1 25
-104.9%
Q4 24
7.0%
-66.7%
Q3 24
-239.9%
Q2 24
-19.4%
Q1 24
-29.4%
Net Margin
MLGO
MLGO
MRVI
MRVI
Q4 25
-71.6%
Q3 25
-61.4%
Q2 25
-83.5%
Q1 25
-63.9%
Q4 24
12.1%
-45.8%
Q3 24
-140.6%
Q2 24
-14.1%
Q1 24
-18.8%
EPS (diluted)
MLGO
MLGO
MRVI
MRVI
Q4 25
$-0.24
Q3 25
$-0.18
Q2 25
$-0.27
Q1 25
$-0.21
Q4 24
$0.56
$-0.21
Q3 24
$-0.68
Q2 24
$-0.07
Q1 24
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MLGO
MLGO
MRVI
MRVI
Cash + ST InvestmentsLiquidity on hand
$319.4M
$216.9M
Total DebtLower is stronger
$291.8M
Stockholders' EquityBook value
$317.6M
$212.4M
Total Assets
$330.8M
$770.6M
Debt / EquityLower = less leverage
1.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MLGO
MLGO
MRVI
MRVI
Q4 25
$216.9M
Q3 25
$243.6M
Q2 25
$319.4M
$269.9M
Q1 25
$285.1M
Q4 24
$164.9M
$322.4M
Q3 24
$578.2M
Q2 24
$66.7M
$573.2M
Q1 24
$561.7M
Total Debt
MLGO
MLGO
MRVI
MRVI
Q4 25
$291.8M
Q3 25
$292.8M
Q2 25
$293.9M
Q1 25
$294.9M
Q4 24
$295.9M
Q3 24
$521.7M
Q2 24
$522.5M
Q1 24
$523.3M
Stockholders' Equity
MLGO
MLGO
MRVI
MRVI
Q4 25
$212.4M
Q3 25
$245.4M
Q2 25
$317.6M
$265.9M
Q1 25
$300.6M
Q4 24
$144.9M
$325.3M
Q3 24
$344.9M
Q2 24
$76.0M
$434.7M
Q1 24
$410.7M
Total Assets
MLGO
MLGO
MRVI
MRVI
Q4 25
$770.6M
Q3 25
$849.2M
Q2 25
$330.8M
$897.0M
Q1 25
$959.8M
Q4 24
$176.3M
$1.0B
Q3 24
$1.3B
Q2 24
$107.6M
$1.4B
Q1 24
$1.4B
Debt / Equity
MLGO
MLGO
MRVI
MRVI
Q4 25
1.37×
Q3 25
1.19×
Q2 25
1.11×
Q1 25
0.98×
Q4 24
0.91×
Q3 24
1.51×
Q2 24
1.20×
Q1 24
1.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MLGO
MLGO
MRVI
MRVI
Operating Cash FlowLast quarter
$-22.8M
Free Cash FlowOCF − Capex
$-24.9M
FCF MarginFCF / Revenue
-49.9%
Capex IntensityCapex / Revenue
4.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-70.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MLGO
MLGO
MRVI
MRVI
Q4 25
$-22.8M
Q3 25
$-15.2M
Q2 25
$-10.3M
Q1 25
$-9.4M
Q4 24
$4.8M
$-14.6M
Q3 24
$13.1M
Q2 24
$17.4M
Q1 24
$-8.5M
Free Cash Flow
MLGO
MLGO
MRVI
MRVI
Q4 25
$-24.9M
Q3 25
$-18.1M
Q2 25
$-13.1M
Q1 25
$-14.6M
Q4 24
$4.8M
$-20.5M
Q3 24
$4.5M
Q2 24
$7.9M
Q1 24
$-14.1M
FCF Margin
MLGO
MLGO
MRVI
MRVI
Q4 25
-49.9%
Q3 25
-43.4%
Q2 25
-27.7%
Q1 25
-31.2%
Q4 24
13.8%
-36.2%
Q3 24
6.6%
Q2 24
11.4%
Q1 24
-22.0%
Capex Intensity
MLGO
MLGO
MRVI
MRVI
Q4 25
4.2%
Q3 25
7.0%
Q2 25
6.1%
Q1 25
11.2%
Q4 24
0.0%
10.3%
Q3 24
12.4%
Q2 24
0.0%
13.8%
Q1 24
8.8%
Cash Conversion
MLGO
MLGO
MRVI
MRVI
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
1.15×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MLGO
MLGO

Segment breakdown not available.

MRVI
MRVI

Cygnus Segment$27.2M54%
Other$18.4M37%
Shipping And Handling$4.3M9%

Related Comparisons